Search

METEOR’s search works in a similar way to other search engines. You can use keywords or terms to pull up related content. The below tips are specific to METEOR and will help you to find what you need.

Try searching using either a keyword, specific term or METEOR ID number.

METEOR ID search

If you’re a returning user and know an item’s METEOR ID, you can enter it in the search box. Clicking the search icon will take you straight to the item’s page.

Autocomplete

METEOR will automatically display suggestions for search terms as you’re typing. This predictive text will show you METEOR entries that exist for the topic you’re searching on. You don’t have to use any of these suggestions, but they may make your searching process faster and easier.

Pressing ‘tab’ will select the top suggestion. Otherwise, selecting from the list of suggestions will put the suggested search term into the search box. You can then click the search icon to find related content. Clicking anywhere on the search results will take you to the item’s page.

Spelling correction

METEOR will show search results with spelling correction. Misspelled terms can still be selected for search where relevant.

Dropdown options

The drop-down menus directly below the search text box allow you to limit the search results to any of the 18 content types in METEOR (see Learn about metadata to view the list), by item creation dates, and item revision dates.

Content types

Content types allow you to limit your search to various metadata building blocks and other topic or help content found in METEOR. See Learn about metadata to view a list of metadata item types that you can search in METEOR. Searching on Topic pages will give results from METEOR’s ‘non-metadata’ pages which explain metadata, how it is managed, how to use METEOR, and how to develop metadata.

Searching on Help will give results from all the pop-up information boxes that are linked to each metadata item. The Help search looks through all text from the METEOR Business Rules, which is accessed through the small ‘i’ icon used throughout the site.

Created date and Revision date

The Created and Revision date dropdown options limit your search to when an item was created or last revised. METEOR will search any time by default, or you can select or specify a custom period.

Custom search syntax

METEOR uses Lucene search syntax. This functionality can be useful to fine-tune your search results even more. Some of the commands include:

  1. Restrict search to the titles of items by using Name: Searchterm. Note that it has to be written exactly as Name, with the capital N. Using name will not work. It doesn’t matter if there’s a space around the colon or not.
  2. Force a second term to be included by using AND.
  3. Widen your search to include another option using the term OR.

For example, if you’re looking for something with the word ‘baby’ in the title you would use Name: baby. METEOR will also give you results for the plural of the search term, so if you search on ‘baby’ you will also get results for ‘babies’. If looking for something with two terms (‘baby’ and ‘admission’) you would use Name: baby AND admission.

Sort by

You can also display your search results with a range of options in the Sort by drop-down menu on the right. You can sort on Relevance, Most/Least Recently Created, Most/Least Recently Updated, and Alphabetically (A–Z and Z–A).

Clear

The Clear button resets the Search page.

Filtering search results

You can fine-tune your search results using the filters that appear in the left-hand menu after searching any term. These filters are dynamic and will only display options specific to your search term, for example, only registration authorities relating to your search term will be displayed. You can use multiple filters at once.

Some of the filters change depending on your role within METEOR. If you are using METEOR without an account, you can search on metadata item type, public registration statuses, METEOR ID, and registration authority. You are also able to compare two items.

If you are using METEOR without an account, you will not be able to save bookmarks for items you’re interested in. There are also some non-public registration statuses that you won’t be able to see.

If you wish to save bookmarks, you can sign up for a free METEOR account easily, just follow the Sign up now prompts after clicking on the Sign In button. If you have an account, you will also be able to subscribe to notifications about changes to specific items in METEOR.

If you are logged in to METEOR as a metadata developer, or any other official role, there are some additional search options. You will be able to restrict your search to the full range of registration status options, including non-public statuses. You will also be able to save bookmarks and subscribe to notifications about changes to items.

Each search result has a small ‘hamburger’ icon on the right . This gives you download links for the metadata item as a PDF or a Word document.


Search

Showing 101-200 of 485 results
Prev 1 3 4 5 Next
Page size:
Cancer-related primary surgery complication type code N[N]

424308 | Value Domain | Cancer Australia
A code set representing types of treatment complication occurring within 30 days of primary surgery for cancer treatment.
Standard: Health

Care coordinator assignment indicator

467844 | Property | Cancer Australia
An indicator of whether a care coordinator has been assigned. The role of a care coordinator is to achieve continuity of care and to ensure that care is delivered in a timely, logical and connected fashion so that both medical and personal needs are met.The assignment of a care coordinator is an indicator of the method of care that is being received.
Standard: Health

Castrate resistance date

587559 | Property | Cancer Australia
The date that two consecutive rising prostate-specific antigen levels (PSA) were found despite castrate levels of testosterone.
Standard: Health

Castrate resistance indicator

492861 | Property | Cancer Australia
An indicator outlining whether a rising prostate-specific antigen (PSA) level, or continued progression of prostate cancer despite castrate levels of testosterone, has been found.
Standard: Health

Cervical cancer staging (FIGO) code N[N]

424187 | Value Domain | Cancer Australia
A code set representing the International Federation of Gynecology and Obstetrics (FIGO) cancer stage values for cervical cancer.
Standard: Health

Chemotherapy

436811 | Glossary Item | Cancer Australia
The treatment of disease by means of chemical substances or drugs, usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis.
Standard: Health

Chemotherapy completion date

393546 | Property | Cancer Australia
The date on which chemotherapy was completed. Chemotherapy is the treatment of disease by means of chemical substances or drugs; the term is usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are adm...
Standard: Health

Chemotherapy cycles administered

393825 | Property | Cancer Australia
The number of cycles of chemotherapy administered. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administer...
Standard: Health

Chemotherapy delay reason code N

424456 | Value Domain | Cancer Australia
A code set representing reasons chemotherapy is delayed.
Standard: Health

Chemotherapy for cancer cluster

561228 | Data Set Specification | Cancer Australia
Chemotherapy is cancer treatment that achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. The chemotherapy cluster consists of those data elements recommended for collection as best practice when the patient is administered chemotherapy as part of the course of treatment for cancer. The chemotherapy cluster collects information on the chemotherapy agent or protocol, the number of cycle...
Standard: Health

Chemotherapy start date

413837 | Property | Cancer Australia
The date on which chemotherapy commenced. Chemotherapy is the treatment of disease by means of chemical substances or drugs; usually used in reference to neoplastic disease. Chemotherapy for the treatment of cancer achieves its antitumour effect through the use of antineoplastic drugs that inhibit the reproduction of cancer cells by interfering with DNA synthesis and mitosis. Chemotherapy may involve treatment with a single agent or a combination of two or more drugs that are administered in tr...
Standard: Health

Clinical trial entry status

430022 | Property | Cancer Australia
The status of clinical trial acceptance.
Standard: Health

Clinical trial entry status code N

430006 | Value Domain | Cancer Australia
A code set representing an individual's clinical trial entry status.
Standard: Health

Clinical trial experimental agent or intervention

487331 | Property | Cancer Australia
The experimental agent or intervention used in a clinical trial. A clinical trial is a controlled experiment involving a defined set of subjects and having a clinical event as an outcome measure. It is intended to yield scientifically valid information about the efficacy or safety of a medical intervention such as, for example, a drug, surgical procedure or diagnostic test.
Standard: Health

Clinical trial funding basis

467776 | Property | Cancer Australia
Whether a clinical trial is funded academically or by industry. Academic funding includes funding from academic institutions or government entities. Industry funding includes funding through private companies that are involved in the provision of pharmaceuticals or equipment that is used for clinical purposes.
Standard: Health

Clinical trial identifier

430961 | Property | Cancer Australia
The scientific/public title and/or registration number used to identify clinical trial(s).
Standard: Health

Clinical trial phase code N

458406 | Value Domain | Cancer Australia
A code set representing the phases of clinical trials.
Standard: Health

Colinet defined comorbidities code N[N]

432983 | Value Domain | Cancer Australia
A code set representing diseases or conditions present at lung cancer diagnosis that are related to non-small cell lung cancer as defined by Colinet and colleagues.
Standard: Health

Core biopsy

598214 | Glossary Item | Cancer Australia
A section of tissue that has been removed in a way that preserves the histological architecture of the tissue's cells. A core biopsy procedure may be used to remove a section of tissue directly from an individual, or biopsy cores may be taken from a larger section of tissue that has been surgically removed from an individual. Core biopsies are most commonly performed as a diagnostic test for cancerous conditions.
Standard: Health

Core biopsy length

587536 | Property | Cancer Australia
The total length of biopsy cores collected from a single tissue specimen in pathology testing of a tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Core biopsy tumour extent

587551 | Property | Cancer Australia
The extent of tissue involved by cancer cells in a single specimen found in pathology testing of tissue. This includes both tissue biopsies and the collection of tissue related to other procedures.
Standard: Health

Core biopsy tumour length

587543 | Property | Cancer Australia
The total length of tissue involved by cancerous tissue in a single specimen found in pathology testing of tissue. This includes both biopsies and the collection of tissue related to other procedures.
Standard: Health

Cytopathology result

425016 | Property | Cancer Australia
The result of the microscopic analysis of cells for the purpose of disease diagnosis.
Standard: Health

Cytopathology result code N

424431 | Value Domain | Cancer Australia
A code set representing the result of a cytopathology test.
Standard: Health

Date clinical trial completed

482211 | Property | Cancer Australia
The date a clinical trial for the treatment of person with cancer is completed.
Standard: Health

Date clinical trial entered

447311 | Property | Cancer Australia
The date on which a patient registers for a clinical trial.
Standard: Health

Date of cancer staging

568595 | Property | Cancer Australia
The date on which cancer staging is completed.Cancer staging is a system of determining the extent or stage of cancer. This date should be equal to the date that the latest pathological or clinical testing required to determine staging occurred. Should the staging be based on surgical findings the date should be equal to the date of the relevant surgery.
Standard: Health

Date of initial medical specialist consultation

456991 | Property | Cancer Australia
The date of the initial consultation with a medical specialist in relation to a specific disease-related symptom or suspected disease diagnosis.
Standard: Health

Date of initial primary health care consultation

456982 | Property | Cancer Australia
The date of the initial consultation with a general practitioner or primary health care practitioner in relation to a specific disease-related symptom or where the instance of a specific disease was first suspected.
Standard: Health

Date of last contact

394052 | Property | Cancer Australia
The date of the most recent contact with the patient.
Standard: Health

Date of referral to psychosocial services

448758 | Property | Cancer Australia
The date a patient was referred to psychosocial services.
Standard: Health

Date of referral to palliative care services

448608 | Property | Cancer Australia
The date a patient is referred to palliative care services. Palliative care is defined as the active total care of patients whose disease is not responsive to curative treatment and may include the control of pain and other symptoms, and of psychological, social and spiritual support. Referral to palliative care services is referral to palliative care administered by palliative care specialists such as a palliative care team or palliative physician. Palliative care may be administered in a com...
Standard: Health

Date of treatment outcome

572842 | Property | Cancer Australia
The date on which the outcome of a course of treatment provided for a particular condition is recorded.
Standard: Health

Depth of cervical cancer invasion

425540 | Property | Cancer Australia
The depth of invasion of a cervical cancer tumour into the cervical wall.
Standard: Health

Depth of myometrial invasion

425532 | Property | Cancer Australia
The depth of tumour invasion into the myometrium. The depth of myometrial invasion is assessed on microscopic examination and is measured from the normal endometrium-myometrium interface (not the surface of the intracavity or exophytic tumour) to the deepest tumour infiltrative focus.
Standard: Health

Diagnosis date of cancer

447400 | Property | Cancer Australia
The date on which cancer was first diagnosed.
Standard: Health

Diagnosis date of first recurrence as distant metastasis

447402 | Property | Cancer Australia
The date of first recurrence as distant metastatic disease. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease-free intermission or remission. Distant metastasis refers to the spread of cancer of the same histology as the original (primary) tumour to distant organs or distant lymph nodes.
Standard: Health

Diagnosis date of first recurrence as locoregional cancer

447405 | Property | Cancer Australia
The date of first recurrence as locoregional cancer. The term recurrence defines the return, reappearance or metastasis of cancer (of the same histology) after a disease free period. Locoregional recurrence refers to the recurrence of cancer cells at the same site as the original (primary) tumour or the regional lymph nodes after a disease free period.
Standard: Health

Diagnostic histology indicator

487260 | Property | Cancer Australia
An indicator of whether a tissue specimen was collected and examined histologically.
Standard: Health

Diagnostic imaging type

431739 | Property | Cancer Australia
The type of medical imaging performed to confirm the diagnosis and determine the nature of a specific disease or condition.
Standard: Health

Diagnostic procedure type

431711 | Property | Cancer Australia
The procedures performed to determine the diagnosis and nature of a specific disease or condition.
Standard: Health

Distant metastatic cancer indicator

545183 | Property | Cancer Australia
An indicator of the existence of distant metastatic cancer. This may be determined through diagnostic or other imaging or procedures. Metastatic cancer is cancer which has spread from the initial site where it developed to other areas of the body. Which anatomical location is determined as a distant site will vary depending on the primary cancer type. Metastatic cancer is generally more common in aggressive cancer types and cancer which is left untreated for a longer period of time.
Standard: Health

Distant metastatic site(s) at diagnosis

433192 | Property | Cancer Australia
The anatomical position (topography) of the secondary or distant metastatic site(s) identified at the time of diagnosis of cancer.
Standard: Health

Distress status in past week

483585 | Property | Cancer Australia
The level of distress experienced over the past week.Distress includes unpleasant experiences of an emotional, psychological, social, or spiritual nature which interfere with the ability to cope.
Standard: Health

Distress thermometer code N[N]

573491 | Value Domain | Cancer Australia
A code set representing the values on the distress thermometer.
Standard: Health

Eastern Cooperative Oncology Group performance status score code N

426026 | Value Domain | Cancer Australia
A code set representing an assessment of how a person's disease affects their daily living abilities.
Standard: Health

Endometrial cancer staging (FIGO) code N[N]

424206 | Value Domain | Cancer Australia
A code set representing the cancer stage values as outlined by the International Federation of Gynecology and Obstetrics (FIGO) for endometrial cancer.
Standard: Health

Erectile dysfunction assessment date

598102 | Property | Cancer Australia
The date that erectile dysfunction was assessed.
Standard: Health

Erectile dysfunction extent

598105 | Property | Cancer Australia
The degree of erectile dysfunction experienced.
Standard: Health

eviQ protocol identifier NNNNNN

444077 | Value Domain | Cancer Australia
The eviQ protocol identifier for the systemic therapy agent protocol.
Standard: Health

External beam radiotherapy type

468066 | Property | Cancer Australia
The type of external beam radiotherapy (XRT). The radiotherapy type relates to the planning target volume (PTV), the imaging type, and the radiotherapy beam arrangement.
Standard: Health

External beam radiotherapy type code N[N]

468083 | Value Domain | Cancer Australia
A code set representing the type of external beam radiotherapy (XRT).
Standard: Health

Extraprostatic extension focality

495226 | Property | Cancer Australia
The focality of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension focality code N

495230 | Value Domain | Cancer Australia
A code set outlining the focality of extraprostatic extension.
Standard: Health

Extraprostatic extension indicator

587667 | Property | Cancer Australia
An indicator of the presence of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension location

587664 | Property | Cancer Australia
The location of extraprostatic extension (EPE) on the prostate.
Standard: Health

Extraprostatic extension location code N[N]

495237 | Value Domain | Cancer Australia
A code set outlining the location of an extraprostatic extension (EPE).
Standard: Health

Faecal incontinence indicator

481973 | Property | Cancer Australia
An indicator of whether a person is experiencing faecal incontinence.
Standard: Health

Fertility counselling offered indicator

567255 | Property | Cancer Australia
An indicator of whether fertility counselling has been offered to an individual. This includes counselling about the potential outcomes of a disease, disorder or related treatment may have on long term fertility and the options in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Fertility counselling provided indicator

567309 | Property | Cancer Australia
An indicator of whether fertility counselling was provided. This includes counselling about the potential outcomes that a disease, disorder or treatment can have on their long term fertility and the options that they have in relation to fertility preservation or treatment options that may have a reduced impact on their fertility.
Standard: Health

Fertility preservation procedure indicator

462737 | Property | Cancer Australia
An indicator of whether a procedure has been performed for the purpose of preserving fertility. This may include the preservation of fertility related tissue or biological material (sperm, eggs or embryos), and/or hormone treatments.
Standard: Health

Fertility preservation procedure type

567412 | Property | Cancer Australia
The type of procedure performed for the purpose of preserving fertility. This may include the preservation of fertility related tissue or biological material (sperm, eggs or embryos), and/or hormone treatments.
Standard: Health

Fertility preservation procedure type code N[N]

462792 | Value Domain | Cancer Australia
A code set representing fertility preservation procedure types.
Standard: Health

Fertility preservation utilised indicator

567511 | Property | Cancer Australia
An indicator of whether tissue preserved for purpose of fertility has been used.
Standard: Health

Genetic event type code N[N]

467911 | Value Domain | Cancer Australia
A code set representing types of genetic events and syndromes.
Standard: Health

Gleason grade code N

392730 | Value Domain | Cancer Australia
An international system of grading prostate cancer based on the tumour patterns in sections of biopsied or resected tissue.
Standard: Health

Gleason score code N[N]

436193 | Value Domain | Cancer Australia
A system of grading prostate cancer based on the sum of the primary and secondary tumour grades/patterns in sections of biopsied or resected tissue.
Standard: Health

Gynaecological cancer (clinical) NBPDS

599620 | Data Set Specification | Cancer Australia
The purpose of the Gynaecological cancer (clinical) National best practice data set (NBPDS) is to define data standards for the national collection of gynaecological cancer data so that data collected is consistent and reliable. The data set is not mandated for collection but is recommended as best practice if gynaecological cancer data is to be collected. It enables individual treatment centres or health service areas to develop collection methods and policies appropriate for their service. The...
Standard: Health

Gynaecological cancer post-radiotherapy complication indicator

546611 | Property | Cancer Australia
An indicator of the occurrence of treatment complications from radiotherapy for the treatment of gynaecological cancer.
Standard: Health

Gynaecological cancer-related radiotherapy complication type code N

424312 | Value Domain | Cancer Australia
A code set representing types of treatment complications occurring within 30 days of radiotherapy for women with gynaecological cancer.
Standard: Health

Health service event—adverse event grade, code N

467449 | Data Element | Cancer Australia
The grade of an adverse event that has occurred during a health service event as defined by the American National Institute of Health and National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE, v4.0), as represented by a code.
Standard: Health

Healthcare provider—organisation identifier, N(16)

426830 | Data Element | Cancer Australia
The Healthcare provider identifier—organisation (HPI-O) is the numerical identifier that uniquely identifies organisations in Australia where healthcare is provided.
Standard: Health

Hereditary genetic events type

564417 | Property | Cancer Australia
The type of genetic mutation that is passed down to further generations in a biological family.
Standard: Health

Hormone therapy

439580 | Glossary Item | Cancer Australia
The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Hormone therapy completion date

393564 | Property | Cancer Australia
The date on which hormone therapy was completed. Hormone therapy is the treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Hormone therapy for cancer cluster

561324 | Data Set Specification | Cancer Australia
Hormone therapy is cancer treatment that achieves its antitumour effect through changes in hormonal balance. It includes the administration of hormones, agents acting via hormonal mechanisms, antihormones and steroids. The hormone therapy cluster consists of those data elements recommended for collection as best practice when the patient is administered hormone therapy as part of the course of treatment for cancer. The hormone therapy cluster collects information on the hormone therapy agent or ...
Standard: Health

Hormone therapy start date

393523 | Property | Cancer Australia
The date on which hormone therapy commenced. The treatment of disease with hormones obtained from endocrine glands or substances that stimulate hormonal effects.
Standard: Health

Identifier N(16)

426832 | Value Domain | Cancer Australia
A unique combination of numbers that identifies an individual or organisation where healthcare is provided within Australia.
Standard: Health

Immediate/short term treatment complication indicator

581057 | Property | Cancer Australia
An indicator of the presence of an immediate or short-term treatment complication (adverse event) during clinical care.This includes, but is not limited to, complications from surgical treatment, such as an unplanned return to theatre, infection or haemorrhage, or complication from drug treatment, such as hypertension or toxicity.
Standard: Health

Immediate/short-term cancer treatment complication outcome code N

467422 | Value Domain | Cancer Australia
A code set representing the outcomes of immediate or short-term treatment complications relating to cancer treatment.
Standard: Health

Immunohistochemistry type

432940 | Property | Cancer Australia
The type of immunohistochemistry stains used to assist in the identification of abnormal cells.
Standard: Health

Immunotherapy

437322 | Glossary Item | Cancer Australia
The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Immunotherapy completion date

393580 | Property | Cancer Australia
The date on which immunotherapy was completed. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Immunotherapy for cancer cluster

561356 | Data Set Specification | Cancer Australia
Immunotherapy, also known as biological therapy, biotherapy or biological response modifier therapy, is cancer treatment that achieves its antitumour effect by altering the immune system or changing the host's response to the tumour cells. The immunotherapy cluster consists of those data elements recommended for collection as best practice when the patient is administered immunotherapy as part of the course of treatment for cancer. The immunotherapy cluster collects information on the immunother...
Standard: Health

Immunotherapy start date

393536 | Property | Cancer Australia
The date on which immunotherapy commenced. The application of immunologic knowledge and techniques to prevent and treat disease.
Standard: Health

Individual Healthcare Identifier

432483 | Property | Cancer Australia
An identifier allocated by Medicare Australia that uniquely identifies each individual in the Australian healthcare system.
Standard: Health

International Federation of Gynecology and Obstetrics cancer staging system

531364 | Classification Scheme | Cancer Australia
The International Federation of Gynecology and Obstetrics cancer staging system is an international system for coding gynaecological cancer, including cervical, endometrial, ovarian and vulval cancer. This system was developed by International Federation of Gynecology and Obstetrics (FIGO) in 1958, and most recently updated in 2009. The two purposes of this system are to allow for comparison of patient treatment and outcomes across both treatment centres and population groups, and to divide pati...
Standard: Health

Late effect indicator

469616 | Property | Cancer Australia
An indicator of whether a late effect appears after the acute stage of a disease or condition has resolved. This is as a result of the treatment, the disease process, or both.
Standard: Health

Late effect type

573455 | Property | Cancer Australia
The type of late effect experienced due to a disease and/or the associated treatment.
Standard: Health

Location of lymphovascular invasion

545101 | Property | Cancer Australia
The location of the invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Lung cancer (clinical) NBPDS

599613 | Data Set Specification | Cancer Australia
The purpose of the Lung cancer (clinical) National best practice data set (NBPDS) is to define data standards for the national collection of lung cancer clinical data so that data collected is consistent and reliable. Collection of this data set is not mandated but it is recommended as best practice if clinical cancer data are to be collected. It will facilitate more consistent data collection while enabling individual treatment centres or health service areas to develop data extraction and coll...
Standard: Health

Lung cancer diagnostic imaging type code N[N]

429492 | Value Domain | Cancer Australia
A code set representing the type of lung cancer diagnostic imaging performed.
Standard: Health

Lung cancer immunohistochemistry type code N[N]

433010 | Value Domain | Cancer Australia
A code set representing immunohistochemical stains used to assist in the diagnosis of lung cancer.
Standard: Health

Lung cancer molecular pathology test results code N[N]

432920 | Value Domain | Cancer Australia
A code set representing the genetic or molecular abnormalities detected in lung cancer molecular pathology testing.
Standard: Health

Lung cancer surgical margin qualifier code N[N]

433048 | Value Domain | Cancer Australia
A code set representing the surgical margin closest to the invasive or in situ lung carcinoma.
Standard: Health

Lymphovascular invasion code N

430724 | Value Domain | Cancer Australia
A code set representing the type of lymphovascular invasion present.
Standard: Health

Lymphovascular invasion indicator

519205 | Property | Cancer Australia
An indicator of whether there is evidence of the invasion of cancer cells into blood vessels and/or the lymphatic system in the pathology specimen.
Standard: Health

Lymphovascular invasion of cervix code N

424173 | Value Domain | Cancer Australia
A code set representing the location of tumour invasion into the lymphatic and/or vascular space for patients with cervical cancer.
Standard: Health

Lymphovascular invasion of corpus uteri code N

424443 | Value Domain | Cancer Australia
A code set representing the location of tumour invasion into the lymphatic and/or vascular space for patients with cancer of the corpus uteri.
Standard: Health

Lymphovascular invasion type

430038 | Property | Cancer Australia
The type of invasion of cancer cells into the blood vessels and/or lymphatic system in a pathology specimen.
Standard: Health

Prev 1 3 4 5 Next
Page size: